| 2026 |
| 10/02 | 1,611 | 1,629 | 1,601 | 1,614 | -1.28% | 2,701,600 | - | +2.41% |
| 10/01 | 1,611 | 1,639 | 1,581 | 1,635 | +0.49% | 2,618,300 | - | +4.14% |
| 09/30 | 1,585 | 1,637 | 1,579 | 1,627 | +4.09% | 3,752,400 | - | +4.23% |
| 09/30 | (空売り報告)モルガン・スタンレーMUFG証券 6,054,769株(1.34%)+0.11% |
| 09/29 | 1,583 | 1,585 | 1,552 | 1,563 | -1.26% | 3,226,000 | - | +0.71% |
| 09/29 | (空売り報告)モルガン・スタンレーMUFG証券 5,549,469株(1.23%)+0.08% |
| 09/28 | 1,590 | 1,600 | 1,581 | 1,583 | -0.75% | 2,273,600 | - | +2.26% |
| 09/25 | 1,595 | 1,618 | 1,583 | 1,595 | +0.31% | 2,081,900 | - | +3.64% |
| 09/24 | 1,595 | 1,621 | 1,584 | 1,590 | -1.24% | 2,677,300 | - | +3.92% |
| 09/24 | (空売り報告)モルガン・スタンレーMUFG証券 5,206,827株(1.15%)+0.11% |
| 09/18 | 1,601 | 1,611 | 1,578 | 1,610 | +0.75% | 3,015,600 | - | +5.85% |
| 09/17 | 1,529 | 1,603 | 1,525 | 1,598 | +5.27% | 3,747,600 | - | +5.76% |
| 09/16 | 1,575 | 1,586 | 1,490 | 1,518 | -4.11% | 4,286,200 | - | +1.07% |
| 09/16 | (空売り報告)Macquarie Bank Limited 2,167,867株(0.48%)-0.09%義務消失 |
| 09/16 | (空売り報告)モルガン・スタンレーMUFG証券 4,682,860株(1.04%)-0.13% |
| 09/15 | 1,569 | 1,598 | 1,554 | 1,583 | +0.96% | 2,346,500 | - | +5.89% |
| 09/14 | 1,521 | 1,584 | 1,498 | 1,568 | +2.69% | 3,597,600 | - | +5.52% |
| 09/11 | 1,540 | 1,563 | 1,516 | 1,527 | -0.59% | 3,411,700 | - | +3.53% |
| 09/11 | (空売り報告)モルガン・スタンレーMUFG証券 5,265,492株(1.17%)-0.09% |
| 09/10 | 1,523 | 1,536 | 1,502 | 1,536 | -0.58% | 3,795,200 | - | +4.85% |
| 09/09 | 1,583 | 1,589 | 1,532 | 1,545 | -4.33% | 4,208,100 | - | +6.19% |
| 09/09 | (空売り報告)モルガン・スタンレーMUFG証券 5,676,306株(1.26%)-0.1% |
| 09/08 | 1,608 | 1,659 | 1,583 | 1,615 | -0.25% | 4,013,800 | - | +12% |
| 09/08 | (空売り報告)Macquarie Bank Limited 2,582,367株(0.57%)-0.1% |
| 09/08 | (空売り報告)モルガン・スタンレーMUFG証券 6,125,590株(1.36%)-0.12% |
| 09/07 | 1,650 | 1,667 | 1,606 | 1,619 | -2.06% | 3,184,700 | - | +13.38% |
| 09/04 | 1,654 | 1,695 | 1,636 | 1,653 | -1.25% | 4,424,700 | - | +16.99% |
| 09/03 | 1,610 | 1,699 | 1,607 | 1,674 | +2.45% | 6,421,000 | - | +19.66% |
| 09/03 | (空売り報告)Macquarie Bank Limited 3,014,367株(0.67%)-0.11% |
| 09/03 | (空売り報告)モルガン・スタンレーMUFG証券 6,684,323株(1.48%)-0.1% |
| 09/02 | 1,572 | 1,653 | 1,567 | 1,634 | +2.77% | 7,280,900 | - | +18.15% |
| 09/01 | 1,546 | 1,597 | 1,535 | 1,590 | +2.32% | 3,524,100 | - | +16.14% |
| 08/31 | (IR情報)11:00 GPIFが採用するESG投資指数の構成銘柄のうち5つに選定 |
| 08/31 | 1,505 | 1,557 | 1,498 | 1,554 | +4.65% | 5,945,800 | - | +14.52% |
| 08/28 | (IR情報)19:00 当社個別財務諸表(日本基準)における退職給付信託返還益(特別利益)計上に関するお知らせ |
| 08/28 | 1,448 | 1,488 | 1,443 | 1,485 | +3.05% | 2,711,900 | - | +10.24% |
| 08/27 | 1,438 | 1,456 | 1,432 | 1,441 | -0.89% | 2,029,800 | - | +7.62% |
| 08/27 | (空売り報告)モルガン・スタンレーMUFG証券 7,105,595株(1.58%)-0.06% |
| 08/26 | (IR情報)16:00 「JPXプライム150指数」構成銘柄への選定に関するお知らせ |
| 08/26 | 1,484 | 1,510 | 1,453 | 1,454 | +0.83% | 4,133,900 | - | +9.08% |
| 08/25 | 1,420 | 1,450 | 1,401 | 1,442 | +1.69% | 2,122,900 | - | +8.67% |
| 08/24 | 1,419 | 1,439 | 1,411 | 1,418 | +0.42% | 2,257,300 | - | +7.51% |
| 08/24 | (空売り報告)モルガン・スタンレーMUFG証券 7,397,395株(1.64%)+0.16% |
| 08/21 | 1,435 | 1,450 | 1,400 | 1,412 | -3.62% | 3,653,100 | - | +7.38% |
| 08/21 | (空売り報告)Macquarie Bank Limited 3,539,867株(0.78%)-0.09% |
| 08/20 | 1,402 | 1,474 | 1,402 | 1,465 | +8.44% | 5,211,700 | - | +11.66% |
| 08/19 | 1,396 | 1,402 | 1,336 | 1,351 | -1.75% | 2,499,000 | - | +3.37% |
| 08/19 | (空売り報告)モルガン・スタンレーMUFG証券 6,684,215株(1.48%)-0.06% |
| 08/18 | 1,360 | 1,400 | 1,359 | 1,375 | +1.4% | 2,509,900 | - | +5.2% |
| 08/17 | 1,388 | 1,395 | 1,356 | 1,356 | -1.17% | 2,291,100 | - | +3.67% |
| 08/14 | 1,378 | 1,378 | 1,350 | 1,372 | +0.66% | 2,465,500 | - | +4.65% |
| 08/14 | (空売り報告)モルガン・スタンレーMUFG証券 6,955,115株(1.54%)+0.08% |
| 08/13 | (IR情報)9:15 米国における「他家iPS 細胞由来網膜シート(立体網膜)を用いた網膜色素変性治療」 フェーズ1/2 試験における最初の被験者への移植のお知らせ |
| 08/13 | 1,360 | 1,367 | 1,344 | 1,363 | +0.96% | 2,684,300 | - | +3.73% |
| 08/12 | 1,332 | 1,350 | 1,317 | 1,350 | +0.37% | 2,596,700 | - | +2.27% |
| 08/12 | (IR情報)8:30 当社に関するレポートについて「Part II-CiRA, Dr.Yamanaka, and the undisclosed history of image duplication concerns」に対する当社の見解 |
| 08/12 | (空売り報告)Macquarie Bank Limited 3,938,067株(0.87%)-0.12% |
| 08/12 | (空売り報告)モルガン・スタンレーMUFG証券 6,559,534株(1.46%)-0.06% |
| 08/10 | 1,300 | 1,358 | 1,291 | 1,345 | +3.86% | 2,989,400 | - | +1.28% |
| 08/10 | (空売り報告)モルガン・スタンレーMUFG証券 6,847,388株(1.52%)-0.1% |
| 08/07 | (IR情報)12:56 当社に関するレポートについて(「Sumitomo Chemical and Sumitomo Pharmaceutical:The 116 Billion yen Swiss Shuffle」に関する追加説明) |
| 08/07 | 1,283 | 1,303 | 1,264 | 1,295 | +0.86% | 2,925,500 | - | -3.14% |
| 08/06 | 1,290 | 1,295 | 1,260 | 1,284 | +0.78% | 3,023,600 | - | -4.54% |
| 08/06 | (空売り報告)モルガン・スタンレーMUFG証券 7,290,788株(1.62%)+0.06% |
| 08/05 | 1,249 | 1,274 | 1,223 | 1,274 | +3.58% | 4,634,400 | - | -5.77% |
| 08/04 | (IR情報)14:22 当社に関するレポートについて |
| 08/04 | 1,217 | 1,277 | 1,188 | 1,230 | -3.23% | 12,627,400 | - | -9.63% |
| 08/04 | (空売り報告)Macquarie Bank Limited 4,455,867株(0.99%)-0.15% |
| 08/04 | (空売り報告)モルガン・スタンレーMUFG証券 7,050,084株(1.56%)+0.62% |
| 08/03 | 1,218 | 1,294 | 1,204 | 1,271 | +1.84% | 6,677,600 | - | -7.43% |
| 08/03 | (空売り報告)Macquarie Bank Limited 5,129,967株(1.14%)+0.17% |
| 08/03 | (空売り報告)モルガン・スタンレーMUFG証券 4,242,790株(0.94%)+0.31% |
| 07/31 | (IR情報)15:30 2026年度(2027年3月期)第1四半期決算(IFRS)補足資料 |
| 07/31 | (IR情報)15:30 2026年度(2027年3月期)第1四半期決算決算説明会資料 |
| 07/31 | (IR情報)15:30 2027年3月期第1四半期決算短信〔IFRS〕(連結) |
| 07/31 | 1,290 | 1,296 | 1,248 | 1,248 | -3.33% | 4,559,700 | - | -9.57% |
| 07/30 | 1,253 | 1,291 | 1,251 | 1,291 | +1.97% | 3,083,400 | - | -7.12% |
| 07/30 | (空売り報告)Macquarie Bank Limited 4,386,667株(0.97%)+0.15% |
| 07/29 | 1,300 | 1,307 | 1,243 | 1,266 | -2.09% | 4,146,900 | - | -9.31% |
| 07/29 | (空売り報告)モルガン・スタンレーMUFG証券 2,856,021株(0.63%)+0.13% |
| 07/28 | 1,306 | 1,312 | 1,267 | 1,293 | -0.61% | 3,264,400 | - | -7.77% |
| 07/28 | (空売り報告)Macquarie Bank Limited 3,713,767株(0.82%)+0.07% |
| 07/28 | (空売り報告)モルガン・スタンレーMUFG証券 2,285,921株(0.5%)再IN |
| 07/27 | 1,290 | 1,301 | 1,265 | 1,301 | +1.25% | 3,356,600 | - | -7.67% |
| 07/27 | (空売り報告)Macquarie Bank Limited 3,400,367株(0.75%)+0.09% |
| 07/24 | 1,261 | 1,285 | 1,249 | 1,285 | -0.08% | 4,242,000 | - | -9.19% |
| 07/24 | (空売り報告)Macquarie Bank Limited 3,008,300株(0.66%)+0.1% |
| 07/23 | 1,285 | 1,311 | 1,280 | 1,286 | 0% | 3,227,300 | - | -9.75% |
| 07/23 | (空売り報告)Macquarie Bank Limited 2,516,700株(0.56%)再IN |
| 07/22 | 1,326 | 1,327 | 1,286 | 1,286 | -1.38% | 3,410,100 | - | -10.26% |
| 07/21 | 1,283 | 1,314 | 1,270 | 1,304 | +3.41% | 3,918,200 | - | -9.51% |
| 07/17 | 1,304 | 1,315 | 1,233 | 1,261 | -4.32% | 5,926,800 | - | -12.79% |
| 07/16 | 1,335 | 1,336 | 1,307 | 1,318 | -0.83% | 2,792,000 | - | -9.17% |
| 07/15 | (IR情報)15:10 再生医療等製品「アムシェプリ」の創製が「第10回バイオインダストリー大賞」を受賞 |
| 07/15 | 1,329 | 1,347 | 1,301 | 1,329 | -0.97% | 4,462,300 | - | -8.47% |
| 07/14 | 1,353 | 1,369 | 1,342 | 1,342 | 0% | 3,680,200 | - | -7.83% |
| 07/13 | 1,415 | 1,417 | 1,340 | 1,342 | -4.14% | 5,279,900 | - | -8.15% |
| 07/10 | 1,425 | 1,426 | 1,392 | 1,400 | -2.3% | 4,514,100 | - | -4.63% |
| 07/09 | 1,440 | 1,454 | 1,420 | 1,433 | -1.17% | 2,181,800 | - | -2.45% |
| 07/08 | 1,550 | 1,554 | 1,449 | 1,450 | -4.92% | 3,594,500 | - | -1.23% |
| 07/07 | 1,552 | 1,557 | 1,509 | 1,525 | -1.8% | 2,542,700 | - | +3.81% |
| 07/06 | 1,575 | 1,582 | 1,544 | 1,553 | -0.26% | 2,541,900 | - | +5.86% |
| 07/03 | 1,545 | 1,569 | 1,526 | 1,557 | +4.5% | 4,211,100 | - | +6.06% |
| 07/02 | 1,484 | 1,508 | 1,447 | 1,490 | +1.15% | 2,823,100 | - | +1.29% |
| 07/01 | 1,472 | 1,502 | 1,453 | 1,473 | -1.87% | 2,751,700 | - | +0.14% |
| 06/30 | 1,520 | 1,542 | 1,496 | 1,501 | -1.83% | 2,661,200 | - | +1.9% |
| 06/29 | 1,474 | 1,536 | 1,472 | 1,529 | +5.89% | 3,729,200 | - | +3.66% |
| 06/26 | 1,456 | 1,478 | 1,434 | 1,444 | -3.35% | 2,905,400 | - | -2.3% |
| 06/25 | (IR情報)15:30 支配株主等に関する事項について |
| 06/25 | 1,440 | 1,504 | 1,425 | 1,494 | +3.61% | 3,920,200 | - | +0.95% |
| 06/24 | 1,431 | 1,467 | 1,431 | 1,442 | +1.84% | 2,794,500 | - | -2.76% |
| 06/23 | 1,453 | 1,471 | 1,416 | 1,416 | -2.48% | 2,253,400 | - | -4.77% |
| 06/22 | 1,486 | 1,488 | 1,445 | 1,452 | -1.22% | 2,501,500 | - | -2.68% |
| 06/19 | 1,506 | 1,518 | 1,452 | 1,470 | -3.61% | 5,422,100 | - | -1.93% |
| 06/18 | 1,527 | 1,546 | 1,491 | 1,525 | +1.87% | 3,247,600 | - | +1.06% |
| 06/17 | 1,481 | 1,531 | 1,479 | 1,497 | +0.67% | 3,105,300 | - | -1.32% |
| 06/16 | 1,534 | 1,538 | 1,480 | 1,487 | +4.79% | 4,847,300 | - | -2.36% |
| 06/15 | 1,382 | 1,438 | 1,377 | 1,419 | +3.2% | 3,469,900 | - | -7.13% |
| 06/12 | 1,391 | 1,398 | 1,341 | 1,375 | +1.03% | 4,740,900 | - | -10.71% |
| 06/11 | 1,389 | 1,395 | 1,347 | 1,361 | -4.09% | 4,574,700 | - | -12.14% |
| 06/10 | 1,460 | 1,462 | 1,406 | 1,419 | -2.94% | 3,955,600 | - | -9.1% |
| 06/09 | 1,508 | 1,519 | 1,449 | 1,462 | -3.5% | 5,026,000 | - | -7.06% |
| 06/08 | 1,520 | 1,568 | 1,489 | 1,515 | +5.43% | 7,440,200 | - | -4.36% |
| 06/05 | (5%ルール)SMBC日興証券(1.55%)三井住友DSアセットマネジメント(0.12%)三井住友銀行(1.56%) |
| 06/05 | 1,434 | 1,489 | 1,432 | 1,437 | +1.55% | 4,200,400 | - | -10.02% |
| 06/04 | 1,474 | 1,501 | 1,415 | 1,415 | -3.02% | 4,881,600 | - | -12.49% |
| 06/03 | 1,464 | 1,479 | 1,419 | 1,459 | -2.34% | 4,915,400 | - | -11.2% |
| 06/02 | (IR情報)10:00 米国臨床腫瘍学会(ASCO)2026における抗がん剤として開発中の新規リポソーム型CHK1阻害剤「SMP-3124LP」に関する臨床データ発表のお知らせ |
| 06/02 | 1,510 | 1,513 | 1,456 | 1,494 | -4.48% | 5,789,600 | - | -10.27% |
| 06/01 | 1,614 | 1,638 | 1,545 | 1,564 | -3.64% | 4,578,800 | - | -7.18% |
| 05/29 | 1,530 | 1,640 | 1,526 | 1,623 | +7.91% | 7,027,200 | - | -4.64% |
| 05/28 | 1,534 | 1,552 | 1,482 | 1,504 | -1.18% | 5,055,800 | - | -12.56% |
| 05/27 | 1,526 | 1,541 | 1,505 | 1,522 | -1.49% | 3,968,500 | - | -12.93% |
| 05/26 | 1,586 | 1,608 | 1,536 | 1,545 | -3.62% | 4,132,100 | - | -12.96% |
| 05/25 | 1,538 | 1,630 | 1,519 | 1,603 | +6.16% | 8,281,300 | - | -10.99% |
| 05/22 | (IR情報)16:40 第三者割当増資の結果(不実施)に関するお知らせ |
| 05/22 | 1,580 | 1,585 | 1,492 | 1,510 | -3.88% | 6,193,000 | - | -16.94% |
| 05/21 | 1,554 | 1,615 | 1,543 | 1,571 | +3.36% | 6,883,300 | - | -14.43% |
| 05/21 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 1,894,117株(0.42%)-0.12%義務消失 |
| 05/20 | 1,530 | 1,554 | 1,477 | 1,520 | -2.38% | 8,323,000 | - | -18.06% |
| 05/19 | 1,594 | 1,595 | 1,527 | 1,557 | -3.89% | 7,428,000 | - | -17.09% |
| 05/18 | 1,686 | 1,686 | 1,595 | 1,620 | -5.21% | 6,792,000 | - | -14.78% |
| 05/15 | 1,683 | 1,720 | 1,613 | 1,709 | -1.44% | 8,989,000 | - | -10.8% |
| 05/15 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 2,453,460株(0.54%)-0.08% |
| 05/14 | 1,688 | 1,804 | 1,671 | 1,734 | +5.09% | 14,480,100 | - | -10.11% |
| 05/14 | (空売り報告)Barclays Capital Securities Ltd 1,896,421株(0.42%)-0.2%義務消失 |
| 05/13 | (IR情報)13:00 2025年度(2026年3月期)決算説明会資料 |
| 05/13 | (IR情報)13:00 2025年度(2026年3月期)決算(IFRS)補足資料 |
| 05/13 | (IR情報)13:00 2026年3月期決算短信〔IFRS〕(連結) |
| 05/13 | 1,634 | 1,699 | 1,481 | 1,650 | +2.48% | 19,041,600 | - | -14.95% |
| 05/13 | (空売り報告)Barclays Capital Securities Ltd 2,802,574株(0.62%)-0.15% |
| 05/13 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 2,813,706株(0.62%)-0.27% |
| 05/12 | (5%ルール)SMBC日興証券(4.38%)三井住友DSアセットマネジメント(0.12%)三井住友銀行(1.56%) |
| 05/12 | 1,685 | 1,704 | 1,603 | 1,610 | -5.85% | 8,441,200 | - | -17.65% |
| 05/12 | (空売り報告)Barclays Capital Securities Ltd 3,465,986株(0.77%)-0.06% |
| 05/11 | 1,653 | 1,720 | 1,595 | 1,710 | +6.01% | 9,822,600 | - | -13.64% |
| 05/11 | (空売り報告)Barclays Capital Securities Ltd 3,735,079株(0.83%)-0.16% |
| 05/07 | (空売り報告)Barclays Capital Securities Ltd 4,455,360株(0.99%)-0.05% |
| 05/07 | (空売り報告)GOLDMAN SACHS INTERNATIONAL 4,005,488株(0.89%)-0.02% |